Calcium, a vital mineral, plays a pivotal role in various physiological processes, with its most recognized function being in bone metabolism. This article provides a comprehensive review of calcium's integral role in bone metabolism, aimed at enhancing healthcare professionals' understanding.
Calcium is crucial in bone formation, a process known as ossification. During ossification, calcium phosphate forms hydroxyapatite crystals that provide strength and rigidity to the bone matrix. Calcium is essential for the mineralization of osteoid tissue laid down by osteoblasts, thereby facilitating bone formation.
Bone remodeling, a continuous process of bone resorption and formation, necessitates calcium. Osteoclasts resorb bone, releasing calcium into the bloodstream. Subsequently, osteoblasts utilize circulating calcium for new bone formation. This balance ensures the maintenance of bone health and mineral homeostasis.
The body tightly regulates calcium levels. Parathyroid hormone (PTH) and calcitonin serve as key regulators. PTH increases blood calcium levels by enhancing bone resorption, increasing intestinal calcium absorption, and reducing renal calcium excretion. Conversely, calcitonin decreases blood calcium levels by inhibiting osteoclast activity.
Understanding the role of calcium in bone metabolism is crucial for healthcare professionals. It informs the management of conditions like osteoporosis and hypocalcemia. Adequate dietary calcium intake, vitamin D supplementation, and appropriate exercise are key strategies for maintaining optimal bone health.
In conclusion, calcium's role in bone metabolism is multifaceted, encompassing bone formation, remodeling, and calcium regulation. As healthcare professionals, a comprehensive understanding of these processes is essential in providing optimal patient care, particularly in conditions affecting bone health.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation